Financial Results and Business Update for the Quarter Ended June 30, 2024 August 8, 2024 Speakers Matthew Gline Richard Pulik Frank Torti, MD Eric Venker, MD, PharmD Mayukh Sukhatme, MD Chief Executive Officer Chief Financial Officer Vant Chair President and Chief Operating Officer President and Chief Investment Officer For investor audiences only 2 Forward-Looking Statements This presentation includes forward-looking statements that are subject to substantial risks and uncertainties that could cause actual ...